HG005

· HuidaGene Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HG005, covering 2025-08-27 to 2025-08-27. Get the full timeline:

Most recent: Clinical Trial Update: An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease [EARLY_Phase 1]